BioSpace News Archive

Albany NY, United States: According to the report, the global minimally invasive surgery market was valued over US$ 8.7 Bn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031.

Loop-mediated isothermal amplification have risen in popularity for DNA amplification. Biologists, clinicians, and researchers have utilized this isothermal amplification method for its marked specificity and selectivity.

Albany NY, United States: Pacemakers were developed in the 1950s and were mainly aimed at treating life-threatening heart blockages that occur after cardiac surgery.

InnoCare Pharma, a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced the Company presented the pre-clinical data of its pan-TRK small molecule inhibitor ICP-723 at the 113th annual meeting of the American Association for Cancer Research in 2022.

The shareholders of Spago Nanomedical AB, corporate registration number 556574-5048 are hereby summoned to the Annual General Meeting on Wednesday May 18, 2022, at 4.00 p.m. CEST in the premises of Advokatfirman Cederquist at Hovslagargatan 3 in Stockholm.

InventisBio Co., Ltd., a clinical-stage biotech company based in Shanghai, China has published the clinical data of their oral KRAS G12C inhibitor D-1553, for the first time in cancer patients.

Orchard Therapeutics, a global gene therapy leader, announced it has reached another historic reimbursement agreement with the Italian Medicines Agency, also known as Agenzia Italiana del Farmaco, to enable access to Libmeldy® for all children with metachromatic leukodystrophy who fall within the scope of the European marketing authorization.

Ardelyx, Inc. today announced that it has reached an agreement with its Japanese collaboration partner, Kyowa Kirin Co. Ltd., to amend the license agreement, originally executed in 2017, that grants to Kyowa Kirin exclusive rights to develop and commercialize Ardelyx’s tenapanor for the treatment of cardiorenal diseases, including hyperphosphatemia, in Japan.

KalVista Pharmaceuticals to Present at 21st Annual Needham Virtual Healthcare Conference.

ITM Announces Successful Completion of Patient Recruitment for its Phase III Trial, COMPETE, with Lead Radiotherapeutic ITM-11.